Flores, Rylie Kiel P.

HRN: 29-27-90  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/09/2026
07/16/2026
PO
7mL
BID
Multiple Abrasions Sec To RCI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines